Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D P Davis

Showing results (91-100 of 230) with videos related to

Pageof 23
Sort By:
International Journal of Dermatology|January 24, 2020
The effects of climate change on human health in Africa, a dermatologic perspective: a report from the International Society of Dermatology Climate Change CommitteeSarah J Coates, Wendemagegn Enbiale, Mark D P Davis, et al.
Archives of Dermatology|October 18, 2006
Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myelomaHans P Sviggum, Mark D P Davis, S Vincent Rajkumar, et al.
Archives of Dermatology|January 20, 2010
Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, MinnesotaMargo J Bendewald, David A Wetter, Xujian Li, et al.
Journal of Drugs in Dermatology : JDD|July 10, 2014
Treatment experience in a local population with hidradenitis suppurativaJohn J Kohorst, Clinton Hagen, Christian L Baum, et al.
Archives of Dermatology|November 23, 2006
Livedoid vasculopathy: further evidence for procoagulant pathogenesisBethany R Hairston, Mark D P Davis, Mark R Pittelkow, et al.
Archives of Dermatology|October 22, 2003
Erythromelalgia: vasculopathy, neuropathy, or both? A prospective study of vascular and neurophysiologic studies in erythromelalgiaMark D P Davis, Paola Sandroni, Thom W Rooke, et al.
Archives of Dermatology|December 17, 2008
Intervention for erythromelalgia, a chronic pain syndrome: comprehensive pain rehabilitation center, Mayo ClinicOlayemi Durosaro, Mark D P Davis, W Michael Hooten, et al.
Archives of Dermatology|August 20, 2003
Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 casesBethany R Hairston, Mark D P Davis, Lawrence E Gibson, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Disabling pansclerotic morphea: clinical presentation in two adultsSherry Henderson Maragh, Mark D P Davis, Alison J Bruce, et al.
The Journal of Investigative Dermatology|November 9, 2013
Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009Sultan A Mirzoyev, Adam G Schrum, Mark D P Davis, et al.
Pageof 23

Showing results (91-100 of 230) with videos related to

Sort By:
Pageof 23
International Journal of Dermatology|January 24, 2020
The effects of climate change on human health in Africa, a dermatologic perspective: a report from the International Society of Dermatology Climate Change CommitteeSarah J Coates, Wendemagegn Enbiale, Mark D P Davis, et al.
Archives of Dermatology|October 18, 2006
Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myelomaHans P Sviggum, Mark D P Davis, S Vincent Rajkumar, et al.
Archives of Dermatology|January 20, 2010
Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, MinnesotaMargo J Bendewald, David A Wetter, Xujian Li, et al.
Journal of Drugs in Dermatology : JDD|July 10, 2014
Treatment experience in a local population with hidradenitis suppurativaJohn J Kohorst, Clinton Hagen, Christian L Baum, et al.
Archives of Dermatology|November 23, 2006
Livedoid vasculopathy: further evidence for procoagulant pathogenesisBethany R Hairston, Mark D P Davis, Mark R Pittelkow, et al.
Archives of Dermatology|October 22, 2003
Erythromelalgia: vasculopathy, neuropathy, or both? A prospective study of vascular and neurophysiologic studies in erythromelalgiaMark D P Davis, Paola Sandroni, Thom W Rooke, et al.
Archives of Dermatology|December 17, 2008
Intervention for erythromelalgia, a chronic pain syndrome: comprehensive pain rehabilitation center, Mayo ClinicOlayemi Durosaro, Mark D P Davis, W Michael Hooten, et al.
Archives of Dermatology|August 20, 2003
Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 casesBethany R Hairston, Mark D P Davis, Lawrence E Gibson, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Disabling pansclerotic morphea: clinical presentation in two adultsSherry Henderson Maragh, Mark D P Davis, Alison J Bruce, et al.
The Journal of Investigative Dermatology|November 9, 2013
Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009Sultan A Mirzoyev, Adam G Schrum, Mark D P Davis, et al.
Pageof 23